Laminin-5-mediated gene expression in human prostate carcinoma cells

Molecular Carcinogenesis

Volumn 30, Issue 2, 2001, Pages 119-129

  Honchel, Ronald ^a   Rosenzweig, Barry A ^a   Thompson, Karol L ^b   Blanchard, Kerry T ^a   Furst, Sylvia M ^a   Stoll, Raymond E ^a   Sistare, Frank D ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

cDNA microarray; DU145; Gene expression; Laminin 5; Prostate carcinoma cells

Indexed keywords

GLYCOPROTEIN; INTEGRIN; KALININ; POLYPEPTIDE;

ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL CYCLE; CELL STRUCTURE; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BLOTTING, NORTHERN; CELL ADHESION MOLECULES; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035120266     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200102)30:2<119::AID-MC1020>3.0.CO;2-N     Document Type: Article

References (82)

1. Extracellular matrix remodelling and cellular differentiation
2. Role of basal lamina in neoplastic disorganization of tissue architecture
3. ECM signalling: Orchestrating cell behaviour and misbehaviour
4. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate
5. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue
6. Identification of laminin-10/11 as a strong cell adhesive complex for a normal and a malignant human epithelial cell line
7. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
8. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits
9. Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere
10. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa
11. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa
12. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5)
13. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa
14. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epiderrnolysis bullosa
15. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas
16. Structure and assembly of hemidesmosomes
17. The assembly of laminin-5 subunits
18. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
19. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue type plasminogen activator
20. The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin
21. The SFL activity secreted by metastatic carcinoma cells is related to laminin 5 and mediates cell scattering in an integrin-independent manner
22. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry
23. Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration, and invasion of malignant glioma cells
24. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane
25. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers
26. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia
27. Altered expression of the hemidesmosome-anchoring filament complex proteins in basal cell carcinoma: Possible role in the origin of peritumoral lacunae
28. Decreased mRNA expression of several basement membrane components in basal cell carcinoma
29. Down-regulation of laminin-5 in breast carcinoma cells
30. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate
31. Epiligrin A new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes
32. A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin
33. Identification of cell binding sites in the laminin α1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides
34. A novel recognition site on laminin for the α3β1 integrin
35. Laminin-binding integrin α7β1: Functional characterization and expression in normal and malignant melanocytes
36. Signal transduction by the alpha 6 beta 4 integrin: Distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes
37. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation
38. Integrins and signal transduction pathways: The road taken
39. Integrin-linked kinase (ILK): A regulator of integrin and growth-factor signalling
40. Integrin signaling
41. The transcriptional program in the response of human fibroblasts to serum
42. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
43. Drug target validation and identification of secondary drug target effects using DNA microarrays
44. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
45. Systematic variation in gene expression patterns in human cancer cell lines
46. A gene expression database for the molecular pharmacology of cancer
47. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
48. The hallmarks of cancer
49. Biosynthesis and secretion of laminin and S-laminin by human prostate carcinoma cell lines
50. Characterization of integrin subunits, cellular adhesion and tumorgenecity of four human prostate cell lines
51. Morphogenetic effects of soluble laminin-5 on cultured epithelial cells and tissue explants
52. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
53. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization
54. Use of a cDNA microarray to analyse gene expression patterns in human cancer
55. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
56. Detecting selective expression of genes and proteins
57. Computational methods for the identification of differential and coordinated gene expression
58. Removal of probes from northern blots
59. Debrin is a widespread actin-associating protein enriched at junctional plaques, defining a specific microfilament anchorage system in polar epithelial cells
60. Different patterns of cytokeratin expression in the normal epithelia of the upper respiratory tract
61. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines
62. Regulation of the transcription factor AP-1 in benign and malignant mouse keratinocyte cells
63. Jun-b inhibits and c-fos stimulates the transforming and transactivating activities of c-jun
64. The matrix-degrading metalloproteinases
65. Control of transcription factors by signal transduction pathways: The beginning of the end
66. The regulation of AP-1 activity by mitogen activated protein kinases
67. AP-1: One switch for many signals
68. JunB is essential for mammalian placentation
69. Matrix metalloproteinases: Multifunctional contributors to tumor progression
70. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth
71. Tissue inhibitors of metalloproteinases: Structure, regulation and biological function
72. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
73. Overexpression of cyclin D1 is rare in human prostate carcinoma
74. RB-mediated tumor suppression of a lung cancer cell line is abrogated by an extract enriched in extracellular matrix
75. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/ E2F pathway
76. The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix
77. Intermediate filaments: A review of the basic biology
78. Neurofilament architecture combines structural principles of intermediate filaments with carboxy-terminal extensions increasing in size between triplet protein
79. Pair formation and promiscuity of cytokeratins: Formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides
80. Nuclear lamins and cytoplasmic intermediate filament proteins: A growing multigene family
81. Rapid spreading and mature hemidesmosome formation in HaCaT keratinocytes induced by incubation with soluble laminin-5r
82. Genomic biology